Professor Ranjeny Thomas

Professor Ranjeny Thomas


Professor of Rheumatology
The University of Queensland, Translational Research Institute
Elected in 2015
Citation on election

Professor Ranjeny Thomas is an NHMRC Research Fellow recognized as an international leader in the field of antigen-specific tolerance in rheumatoid arthritis (RA). During the last 5 years, she reported the first clinical trial of antigen-specific dendritic cell therapy in RA, and attracted investment from the US-based Johnson and Johnson group of companies into Dendright, a start-up company commercialising immunotherapy for RA co-invented and patented by Thomas. If fully realized, this work will be transformative for human health in the next decade. Her research leadership is demonstrable in 2 successful program grant awards as CIA and 2 investigator-driven translational clinical trials.

Keep up to date with the latest news

By providing your email address, you consent to it being added to our mailing list.